34 results
PRE 14A
BDTX
Black Diamond Therapeutics Inc
12 Apr 24
Preliminary proxy
4:48pm
an understanding of the fiduciary responsibilities that are required of a member of the board of directors and the commitment of time and energy … acumen, integrity and an ability to exercise sound judgment, as well as a commitment of service to the Company and our board of directors.
The following
8-K
EX-99.1
BDTX
Black Diamond Therapeutics Inc
18 Sep 23
Black Diamond Therapeutics Announces CEO Transition
7:12am
contributions to Black Diamond, and his commitment to exceptional science and to patients in need.“
Dr. Velleca joined the Board of Directors of Black
8-K
EX-10.2
amsbq2a5ri
18 Sep 23
Black Diamond Therapeutics Announces CEO Transition
7:12am
8-K
EX-1.1
8nrlo
30 Jun 23
Entry into a Material Definitive Agreement
4:03pm
424B5
x7s84n8v7d
30 Jun 23
Prospectus supplement for primary offering
4:01pm
424B5
7el2lwm1couut3bq 60t
29 Jun 23
Prospectus supplement for primary offering
6:02am
8-K
EX-99.1
3a483qpog0wg
9 May 23
Black Diamond Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
7:43am
8-K
EX-99.1
udqm47u38hkvg
19 Dec 22
Black Diamond Therapeutics Announces Changes to Board of Directors
8:20am
S-3
8algw0gj
14 Nov 22
Shelf registration
4:15pm
DEF 14A
c3p89
27 Apr 21
Definitive proxy
4:06pm
S-3ASR
l4o89jgp
1 Feb 21
Automatic shelf registration
5:28pm
S-3ASR
EX-1.2
4axt gn88umq
1 Feb 21
Automatic shelf registration
5:28pm
10-K
f83nv9e8xqdexok2ii
24 Mar 20
Annual report
7:47am